is tirzepatide same as glp 1 Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Compound Tirzepatide Vs GLP-1 Medications:

37 Some studies suggest that lean mass loss with GLP-1 RAs can constitute 20-50%, sometimes even up to 60%, of total weight lost, although this proportion is often similar to or slightly better than diet-only approaches

1,2 The use of these medications is rapidly expanding as they gain in popularity and receive FDA approvals across multiple disease states

One example escalation schedule observed in Phase 2 obesity trials proceeded broadly as follows: Weeks 14: 2 mg once weekly (initiation phase) Weeks 58: 4 mg once weekly Weeks 912: 8 mg once weekly Weeks 13 onwards: Up to 12 mg once weekly (the maximum dose explored in Phase 2 trials) This is an illustrative example only

Pharmacovigilance Risk Assessment Committee (PRAC): minutes of the meeting 7-10 January 2013

November 6, 2025

95% CI, 1.11 to 2.78)